David Baker Email and Phone Number
David Baker work email
- Valid
- Valid
- Valid
- Valid
- Valid
David Baker personal email
David Baker phone numbers
Accomplished life sciences executive with experience in large, medium, and small/start up pharmaceutical companies. Brand management leadership experience on five different billion dollar brands in three therapeutic categories.Specialties: Executive leadership; Marketing; Product Launches; Commercial Assessment; Business Development & Licensing; Analysis; Fund Raising; Problem Solving; Mentoring and Developing Talent
Nospharma
View- Website:
- nospharma.ca
- Employees:
- 3
-
Head Of Corporate DevelopmentNospharmaPhiladelphia, Pa, Us
-
Board DirectorDevonian Health Group Inc. May 2023 - PresentLaval, Québec, CaDevonian (TSXV: GSD; OTCQB: DVHGF) is a late stage botanical pharmaceutical corporation with novel therapeutic approaches targeting worldwide unmet medical needs. Devonian’s core strategy is to develop prescription botanical drugs which could be from plant materials, algae, macroscopic fungi, and combinations thereof. This strategy is supported by FDA set of regulatory guidelines, favouring a more efficient drug development pathway for prescription botanical drug products. -
Board DirectorGri Bio, Inc. Apr 2023 - PresentSan Diego, Ca, UsGRI Bio (NASDAQ: GRI) is a clinical-stage biopharmaceutical company focused on fundamentally changing the way inflammatory, fibrotic and autoimmune diseases are treated. GRI’s therapies are designed to target the activity of NKT cells, which are key regulators earlier in the inflammatory cascade, to interrupt disease progression and restore the immune system to homeostasis. -
Head Of Corporate DevelopmentNospharma Jul 2023 - PresentMontreal, Quebec, CaNospharma is a preclinical therapeutics company developing innovative treatments for rare genetic neurodevelopmental disorders, including Fragile X Syndrome, SynGAP1 Syndrome, and GRIN Disorder. Our technology comes from research originally conducted at the Bowie Lab at McGill University. We aim to deliver novel and effective therapeutics as quickly as possible to make a lasting difference in the lives of millions of patients and their caring families.
-
MemberRobin Hood Ventures Jun 2023 - PresentPhiladelphia, Pa, UsRobin Hood Ventures is a group of angel investors, focused on early-stage, high-growth companies in the Greater Philadelphia region. We help entrepreneurs build great companies, providing capital, mentoring, expertise and connections to help companies reach their potential. -
Board DirectorBenchworks Aug 2018 - May 2024Ambler, Pennsylvania, UsBenchworks is a company comprised of a steadily growing number of business units and wholly owned subsidiaries primarily dedicated to serving the life science industry. Benchworks operating units include Benchworks Health, a strategic communications firm with offices in Chestertown, Maryland and Philadelphia. -
President & CeoVallon Pharmaceuticals Jan 2019 - May 2023Philadelphia, Pennsylvania, UsTook company public in 2021. Led company through M&A process resulting in successful merger with GRI Bio (NASDAQ: GRI). -
Chief Operating Officer & Acting CeoVallon Pharmaceuticals Jan 2018 - Dec 2018Philadelphia, Pennsylvania, UsVallon Pharmaceuticals Inc. (NASDAQ: VLON), founded in 2018 and headquartered in Philadelphia, is an emerging pharmaceutical company focused on the development of new medications to help patients with central nervous system (CNS) disorders including ADHD and Narcolepsy. ADAIR (Abuse Deterrent Amphetamine Immediate Release) is the company’s lead investigational product candidate.
-
Interim CeoAlcobra Jun 2017 - Nov 2017Tel Aviv, IlLed company through M&A process resulting in successful merger with Arcturus Therapeutics (NASDAQ: ARCT). -
Chief Commercial OfficerAlcobra Jan 2014 - Jun 2017Tel Aviv, IlAlcobra Ltd., was a Tel Aviv-based pharmaceutical company focused on the development of new medications to help patients with cognitive disorders including ADHD and Fragile X Syndrome. Led all pre-launch commercial analysis and preparation for all pipeline products, as well as leading business development efforts and supporting investor relations.
-
Vice President, Innovation & Imagination - Behavioral Health Business UnitShire Pharmaceuticals Jun 2012 - Dec 2013Tokyo, Jp, JpIdentified, evaluated, licensed, and developed novel products and services that meet unmet needs for patients with Behavioral Health disorders including ADHD, Autism, Binge Eating Disorder, Depression and PTSD. These products and services included and went beyond Rx therapies including diagnostics, complementary therapy, and mHealth tools and applications. -
Vice President, Commercial Lead - Adhd Business UnitShire Pharmaceuticals Feb 2009 - Jun 2012Tokyo, Jp, JpOversaw portfolio decisions for multi-product business unit; Built pipeline of future ADHD and CNS products through acquisition and development; Led efforts to geographically expand ADHD/CNS product line beyond North America and Western Europe; Led newly formed Customer & Patient Excellence team
-
Vice President, Product General ManagerShire Pharmaceuticals Aug 2006 - Feb 2009Tokyo, Jp, JpGeneral Manager with global responsibilities for Vyvanse and Adderall XR across Marketing, Sales, R&D, Regulatory, and Manufacturing functions with full P&L accountability
-
Vice President, Marketing, Adhd ProductsShire Pharmaceuticals Apr 2004 - Aug 2006Tokyo, Jp, JpHead of US Marketing for multiple ADHD products both on the market and under development including Vyvanse, Adderall XR, Daytrana, Intuniv, and SPD 465
-
Senior Director Of MarketingMerck 1990 - 2004Multiple positions in Marketing, Marketing Support, Market Development ( MSL Manager), Business Development, and Market Research with experience on multiple brands including Fosamax, Zocor, Mevacor, and Maxalt
-
Account ExecutiveTravelers Insurance 1985 - 1988New York, Ny, UsProperty-casualty insurance underwriter for mid-large accounts ($100,000 - $2,000,000)
David Baker Skills
David Baker Education Details
-
Duke University - The Fuqua School Of BusinessMarketing -
Duke UniversityEconomics
Frequently Asked Questions about David Baker
What company does David Baker work for?
David Baker works for Nospharma
What is David Baker's role at the current company?
David Baker's current role is Head of Corporate Development.
What is David Baker's email address?
David Baker's email address is db****@****ire.com
What is David Baker's direct phone number?
David Baker's direct phone number is +148459*****
What schools did David Baker attend?
David Baker attended Duke University - The Fuqua School Of Business, Duke University.
What are some of David Baker's interests?
David Baker has interest in Children, Economic Empowerment, Education, Science And Technology, Health.
What skills is David Baker known for?
David Baker has skills like Strategy, Pharmaceutical Industry, Product Launch, Leadership, Cross Functional Team Leadership, Market Research, Strategic Planning, Pharmaceutical Sales, Marketing Strategy, Business Development, Management, Sales Effectiveness.
Free Chrome Extension
Find emails, phones & company data instantly
Aero Online
Your AI prospecting assistant
Select data to include:
0 records × $0.02 per record
Download 750 million emails and 100 million phone numbers
Access emails and phone numbers of over 750 million business users. Instantly download verified profiles using 20+ filters, including location, job title, company, function, and industry.
Start your free trial